Review the fundamental analyses we have available of the companies that are dedicated to Pharmaceutical

Assets comparison
Assets 21,875M$
Indebtedness 134%
Profit 1,006M$
ROE 11.75%
Assets
Indebtedness
Profit
ROE
Employees